(0.32%) 5 116.17 points
(0.38%) 38 386 points
(0.35%) 15 983 points
(0.02%) $82.65
(0.74%) $2.05
(-0.48%) $2 346.50
(-0.98%) $27.39
(-0.28%) $958.80
(-0.17%) $0.933
(-0.25%) $11.00
(-0.53%) $0.796
(1.56%) $93.31
-2.65% $ 0.511
Live Chart Being Loaded With Signals
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation...
Stats | |
---|---|
Tagesvolumen | 460 710 |
Durchschnittsvolumen | 437 269 |
Marktkapitalisierung | 19.42M |
EPS | $0 ( 2024-04-04 ) |
Nächstes Ertragsdatum | ( $0 ) 2024-05-13 |
Last Dividend | $0.240 ( 2023-01-13 ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.0247 |
ATR14 | $0.0370 (7.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-11-20 | Luo Ying | Buy | 3 350 897 | Stock Option (Right to Buy) |
2023-10-30 | Luo Ying | Buy | 2 840 376 | Common Stock |
2023-11-20 | Luo Ying | Buy | 2 262 755 | Stock Option (Right to Buy) |
2023-11-20 | Ye Weiguo | Buy | 1 665 115 | Stock Option (Right to Buy) |
2023-11-20 | Ma Songjiang | Buy | 4 510 047 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
24.25 |
Last 85 transactions |
Buy: 88 748 347 | Sell: 111 334 812 |
Volumen Korrelation
Catalyst Biosciences Inc Korrelation
10 Am meisten positiv korreliert | |
---|---|
CALA | 0.925 |
ODT | 0.917 |
UPC | 0.909 |
BCAB | 0.908 |
NBIX | 0.897 |
LLNW | 0.891 |
ENNV | 0.891 |
LFMD | 0.891 |
XPDI | 0.889 |
YJ | 0.889 |
10 Am meisten negativ korreliert | |
---|---|
SHC | -0.922 |
WYNN | -0.921 |
DSPG | -0.917 |
ACLS | -0.913 |
PPD | -0.908 |
BNIX | -0.907 |
DUNE | -0.906 |
RVNC | -0.902 |
HHGC | -0.901 |
FWONK | -0.899 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Catalyst Biosciences Inc Korrelation - Währung/Rohstoff
Catalyst Biosciences Inc Finanzdaten
Annual | 2022 |
Umsatz: | $794 000 |
Bruttogewinn: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2022 |
Umsatz: | $794 000 |
Bruttogewinn: | $-4 000.00 (-0.50 %) |
EPS: | $-0.260 |
FY | 2021 |
Umsatz: | $0.00 |
Bruttogewinn: | $-7.38M (0.00 %) |
EPS: | $-2.87 |
FY | 2020 |
Umsatz: | $20.95M |
Bruttogewinn: | $11.79M (56.26 %) |
EPS: | $-2.93 |
Financial Reports:
No articles found.
Catalyst Biosciences Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$1.430 (N/A) |
$0 (N/A) |
$0.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $59.77 | 2015-08-20 |
Last Dividend | $0.240 | 2023-01-13 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 3 | -- |
Total Paid Out | $61.44 | -- |
Avg. Dividend % Per Year | 39.53% | -- |
Score | 4.37 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.002 | |
Div. Directional Score | 0.464 | -- |
Year | Amount | Yield |
---|---|---|
2015 | $59.77 | 22.00% |
2016 | $0 | 0.00% |
2017 | $0 | 0.00% |
2018 | $0 | 0.00% |
2019 | $0 | 0.00% |
2020 | $0 | 0.00% |
2021 | $0 | 0.00% |
2022 | $1.430 | 143.00% |
2023 | $0.240 | 41.00% |
2024 | $0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
SLVO | Dividend Royal | 2023-11-20 | Monthly | 12 | 10.77% | 8.50 |
QYLD | Dividend Royal | 2023-11-20 | Monthly | 11 | 7.50% | 8.50 |
PSEC | Dividend Royal | 2023-12-26 | Monthly | 21 | 7.04% | 8.50 |
GAIN | Dividend Royal | 2023-12-04 | Monthly | 20 | 8.19% | 8.50 |
GLDI | Dividend Royal | 2023-11-20 | Monthly | 12 | 7.15% | 8.50 |
OXLC | Dividend Royal | 2023-12-14 | Monthly | 14 | 10.00% | 8.50 |
OXSQ | Dividend Diamond | 2023-12-14 | Monthly | 21 | 9.10% | 8.50 |
HRZN | Dividend King | 2023-12-18 | Monthly | 15 | 6.60% | 8.45 |
USOI | Dividend Royal | 2023-11-20 | Monthly | 8 | 16.70% | 8.28 |
PFLT | Dividend King | 2023-11-15 | Monthly | 14 | 6.50% | 8.27 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 55.72 | 1.500 | 10.00 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | -0.709 | 1.200 | -10.00 | -10.00 | [0 - 0.3] |
returnOnEquityTTM | 12.04 | 1.500 | 10.00 | 10.00 | [0.1 - 1] |
payoutRatioTTM | -0.289 | -1.000 | -2.89 | 2.89 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -71.39 | 1.000 | -10.00 | -10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.176 | -0.352 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 3.15 | 1.000 | 10.00 | 10.00 | [0.2 - 0.8] |
operatingProfitMarginTTM | 55.75 | 1.000 | 10.00 | 10.00 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | -0.0127 | 0.800 | -3.42 | -2.73 | [0.5 - 2] |
Total Score | -0.0749 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -0.439 | 1.000 | -0.145 | 0 | [1 - 100] |
returnOnEquityTTM | 12.04 | 2.50 | 10.00 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.352 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | -0.352 | 2.00 | -0.117 | -0.235 | [0 - 30] |
payoutRatioTTM | -0.289 | 1.500 | -2.89 | 2.89 | [0 - 1] |
pegRatioTTM | -0.00352 | 1.500 | -3.36 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 16.85 | 1.000 | 10.00 | 0 | [0.1 - 0.5] |
Total Score | 1.002 |
Catalyst Biosciences Inc
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing protease product candidates in the fields of hemostasis and complement regulation. The company's protease engineering platform creates improved or novel molecules to treat diseases that result from dysregulation of the complement system. It develops CB 2782-PEG, a component 3 (C3) degrader for the treatment of dry age-related macular degeneration (dAMD); and CB 4332 for patients with deficiencies in complement factor I (CFI), including dAMD. The company also develops ProTUNE C3b/C4b degrader and ImmunoTUNE C3a/C5a degrader platforms designed to target other disorders of the complement or inflammatory pathways. It has a strategic research collaboration with Mosaic Biosciences, Inc.; and license and collaboration agreement with Biogen International GmbH. Catalyst Biosciences, Inc. was founded in 2002 and is headquartered in South San Francisco, California.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.